跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
alpha-galactosylceramide
首页
药物
alpha-galactosylceramide
alpha-galactosylceramide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Analogs of Alpha Galactosyceramide and Uses thereof
US 2009239813 A1
申请人: CERUNDOLO VINCENZO
优先权: 2006
CN
US
6 件公开
Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide
US 8802098 B2
申请人: AHONEN CORY
优先权: 2008
US
5 件公开
VACCINE COMPRISING NATURAL KILLER CELLS LOADED WITH LIGANDS OF NATURAL KILLER T CELLS AND CANCER ANTIGENS
EP 4541369 A4
申请人: CELLID CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
VACCINE COMPRISING PERIPHERAL BLOOD MONONUCLEAR CELLS LOADED WITH NATURAL KILLER T CELL LIGAND AND ANTIGEN
EP 4552646 A4
申请人: CELLID CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
COMPOSITIONS AND METHODOLOGY FOR DELIVERY OF ALPHA-GALACTOSYLCERAMIDE COMPOUNDS
EP 4698228 A1
申请人: ENGENEIC MOLECULAR DELIVERY PTY LTD
优先权: 2023
CN
EP
WO
3 件公开
Vaccine Composition Comprising Alpha-Galactosylceramide as an Adjuvant For Intranasal Administration
US 2008317769 A1
申请人: KANG CHANG-YUIL
优先权: 2005
CN
US
2 件公开
ALPHA-GALACTOSYLCERAMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION FOR THE IMMUNE ADJUVANT CONTAINING THE SAME AS AN ACTIVE INGREDIENT
US 2010104590 A1
申请人: SNU R&DB FOUNDATION
优先权: 2006
CN
US
2 件公开
Use of glycosylceramides as adjuvants for vaccines against infections and cancer
US 7488491 B2
申请人: UNIV NEW YORK
优先权: 2002
US
2 件公开
Esterified alpha-galactosylceramide
US 8580751 B2
申请人: SHIOZAKI MASAO
优先权: 2008
US
2 件公开
Nanoparticle formulated glycolipid antigens for immunotherapy
US 8546371 B2
申请人: ZHOU DAPENG
优先权: 2011
US
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈